“Our results demonstrate that synthetic biomarkers can be engineered to sense vascular diseases remotely from the urine”
Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal. But scientists are now reporting progress in the form of a simple urine test. Their study, in which they demonstrated that the test works using laboratory mice, appears in the journalACS Nano.
Sangeeta N. Bhatia and colleagues, including lead author and Ph.D. candidate Kevin Lin and postdoctoral fellow Gabriel Kwong, point out that blood clots — clumps of platelets and fibrin proteins — can threaten to choke off blood flow and lead to a wide range of serious and sometimes fatal conditions including atherosclerosis and stroke. Usually, blood clots are a good thing. They form a plug that stops the bleeding after an injury. But sometimes, a clot forms when it really isn’t needed, such as when a person sits too long on a long-distance flight and develops “deep-vein thrombosis.” In that case, a clot forms in the leg, blocking blood flow and causing leg pain. But it also can dislodge and move throughout the body to the heart or even the brain, which is life-threatening. Diagnosing a blood clot, or thrombosis, is tricky, however, and current clinical tests aren’t always reliable. Bhatia’s team wanted to develop a simple and more reliable way to test for these obstructive blood clots.
They describe development and testing of “synthetic biomarkers” — lab-made materials for detecting what is going on in the body. They added small pieces of proteins called peptides onto nanomaterials that are similar to those already approved and used in the clinic. They injected the tiny nanomaterials into mice, which are stand-ins for humans. The peptides got chopped up if a blood clot was actively forming in the mice, and those peptide fragments were detected in a simple urine test. “Our results demonstrate that synthetic biomarkers can be engineered to sense vascular diseases remotely from the urine and may allow applications in point-of-care diagnostics,” the researchers state.
Go deeper with Bing News on:
Detecting blood clots
- Warning to all dog walkers as 'flesh-eating' disease on rise and vets say 'you need to know'
Dog owners are being alerted to the increasing threat of Alabama rot, a deadly "flesh-eating" disease that can lead to kidney failure in pets. Petsure's vet Dr Corinne Wigfall has emphasised the ...
- A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in medicine
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...
- AI-assisted ultrasounds may better detect joint bleeding, inflammation
Artificial intelligence can comb through ultrasounds to detect joint bleeding and inflammation in hemophilia, and help speed diagnosis, a study says.
- Astronomers Finally Detect a Rocky Planet with an Atmosphere
Astronomers have searched for years for rocky planets beyond our solar system with an atmosphere - a trait considered essential for any possibility of harboring life. Well, they finally seem to have ...
- New sensor detects errors in MRI scans
A new prototype sensor is capable of detecting errors in MRI scans using laser light and gas. The new sensor can thereby do what is impossible for current electrical sensors -- and hopefully pave the ...
Go deeper with Google Headlines on:
Detecting blood clots
[google_news title=”” keyword=”Detecting blood clots” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Synthetic biomarkers
- The Diagnostic Value of Biomarkers (SteatoTest) for the Prediction of Liver Steatosis
The aim of this study was to identify a panel of biomarkers (SteatoTest), with sufficient predictive values, for the non-invasive diagnosis of steatosis in patients with or without chronic liver ...
- Electronic Skin Patch Market worth $27.0 billion by 2029 - Exclusive Report by MarketsandMarkets™
The Electronic Skin Patch market is projected to grow from USD 15.0 billion in 2024 and is estimated to reach USD 27.0 billion by 2029; it ...
- Several Novel Injectables Show Early Promise in Knee Osteoarthritis
Data on several novel injectable drugs were presented at the World Congress on Osteoarthritis, as well as updated data on the gene therapy XT-150.
- Project Based Lessons - Natural Resources & Synthetic Materials
Synthetic materials are made from natural resources. Synthetic materials are made by chemically changing the starting substances to create a material with different characteristics. Some examples of ...
- The global synthetic drugs crisis has hit West Africa, where people are digging up human bones to make a drug called 'kush'
Cemeteries are bolstering their security measures because gravediggers are stealing human bones to make powerful synthetic drugs, local journalists told Business Insider. Sierra Leone, in West ...
Go deeper with Google Headlines on:
Synthetic biomarkers
[google_news title=”” keyword=”synthetic biomarkers” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]